TotalMarketCap

BeOne Medicines

ONCNasdaq Cayman IslandsHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$40.713 B

$358.07 -0.20%

Close of 5 Oct 2026

As of 5 Oct 2026, BeOne Medicines (ONC) has a market capitalization of $40.7B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$5.34B

#639 by revenue

Earnings

$286.9M

#858 by earnings

Shares outstanding

1,478,124,405

Latest filing cover page

P/E ratio

141.9

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →
  1. #15Takeda PharmaceuticalTAK$56.4B
  2. #16Teva Pharmaceutical IndustriesTEVA$46.1B
  3. #17BeOne MedicinesONC$40.7B
  4. #18Royalty PharmaRPRX$32.9B
  5. #19Alnylam PharmaceuticalsALNY$29.4B

What if BeOne Medicines were worth as much as…

Open the what-if tool →

Gold $28.7T

$252,494.74

Per share 705× higher

Bitcoin $1.72T

$15,132.59

Per share 42.3× higher

Nvidia $5.64T

$49,587.53

Per share 138× higher

Or at a round number

$50.0B$100.0B$200.0B$500.0B

Where these numbers come from

Share counts and financials for BeOne Medicines are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 6 Oct 2026. Read the methodology.